Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,718.00p
   
  • Change Today:
      13.00p
  • 52 Week High: 1,885.00p
  • 52 Week Low: 1,135.00p
  • Currency: UK Pounds
  • Shares Issued: 135.92m
  • Volume: 36,110
  • Market Cap: £2,335.05m
  • RiskGrade: 314

Indivior lifts 2021 guidance after better-than-expected H1

By Michele Maatouk

Date: Wednesday 30 Jun 2021

LONDON (ShareCast) - (Sharecast News) - Opioid addiction treatment maker Indivior lifted its 2021 guidance on Wednesday following a better-than-expected business performance through the first half of the year.
The company now expects total full-year revenue of between $705m and $740m, up from previous guidance of up to $625m. This reflects a stronger performance from its Sublocade drug, a continued more modest rate of Soboxone film market share erosion for the remainder of the year and FX benefits of around $10m.

For Sublocade, its now expects FY revenue of between $210m and $230m, up from guidance of between $185m and $210m. This is based stronger demand and a large order from a new criminal justice system customer.

The company's revenue guidance for Perseris was unchanged at between $17m and $20m.

Indivior also said its adjusted gross margin is set to be in the low-80%s range, modestly above previous expectations due to relative stability in the commercial channel for Suboxone film.

Meanwhile, adjusted operating expenses will be in the range of $470m to $480m, compared to $420m to $440m expected previously.

Indivior did not provide any numbers but said it expects a "significantly higher" level of positive adjusted pre-tax income than previously.

At 1230 BST, the shares were up 5% at 152.40p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,718.00p
Change Today 13.00p
% Change 0.76 %
52 Week High 1,885.00p
52 Week Low 1,135.00p
Volume 36,110
Shares Issued 135.92m
Market Cap £2,335.05m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.04% below the market average55.04% below the market average55.04% below the market average55.04% below the market average55.04% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Price Trend
66.97% above the market average66.97% above the market average66.97% above the market average66.97% above the market average66.97% above the market average
85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average
Income Not Available
Growth
50.07% above the market average50.07% above the market average50.07% above the market average50.07% above the market average50.07% above the market average
8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
13:08 45 @ 1,718.00p
12:56 53 @ 1,717.00p
12:56 197 @ 1,717.00p
12:56 163 @ 1,719.00p
12:56 293 @ 1,719.00p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page